CSE | FSE

Health·Wellness·Science

Strategic Investing

Nova Mentis Life Science Corp. (formerly Liberty Leaf Holdings Ltd.) is a Canadian-based, public company whose focus is to build and support a diversified portfolio of health and wellness businesses.

Our Holdings

just kush
just kush

Nova Mentis Life Science
Stock Performance

CSE FSE

Latest News

Nova Mentis Life Science Signs Agreement to Acquire 100% of Psychedelic-Focused Autism Research Company Pilz BioScience Corp.

VANCOUVER, BC, Oct. 9, 2020 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce it has signed a non-binding letter of intent (“the LOI”) to acquire 100 percent of the issued and outstanding securities of privately-held Pilz Bioscience Corp. (“Pilz”) by way of a share exchange or other such business combination as deemed appropriate (the “Transaction”). Pilz is a research driven biotechnology company that aims to develop medicinal psychedelics for

FORMER SENIOR LEADER OF APOTEX JOINS NOVA MENTIS LIFE SCIENCE BOARD AND IS NAMED COO

Vancouver, British Columbia – September 17, 2020 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce the appointment of Ms. Jacqueline McConnell to its Board of Directors and as Chief Operating Officer (“COO”). Jacqueline McConnell has over twenty years of experience working for Apotex Inc., one of Canada’s largest pharmaceutical companies. She provides critical business strategy input at a senior leadership level to support an organization’s ability to achieve local and global growth and corporate sustainability.